OBJECTIVE: We re-evaluated reported associations between tobacco use and other factors and non-Hodgkin lymphoma (NHL) t(14; 18)-subtypes based on fluorescence in situ hybridization (FISH) assays believed to be more sensitive than polymerase chain reaction (PCR), previously used for detecting t(14; 18). METHODS: Commercial FISH assays and bcl-2 immunostaining were performed on paraffin sections to determine t(14; 18) and bcl-2 case-subtypes. Polytomous logistic regression models estimated associations between NHL case-subtypes (versus 1,245 population-based controls) and tobacco use as well as other factors. RESULTS: Adjusting for age, state, and proxy status, t(14; 18)-negative NHL was associated with any tobacco use (vs. no tobacco use, OR = 1.9, 95% CI = 1.0-3.5), including current smoking (vs. no cigarette use, OR = 1.9, 95% CI = 1.1-3.2). Tobacco exposures were not clearly associated with t(14; 18)-positive NHL or bcl-2 case-subtypes. Hair-dye use and family history of a hemolymphatic cancer were associated with t(14; 18)-negative NHL, but the number of exposed cases was small. CONCLUSIONS: The association between t(14; 18)-negative NHL and cigarette smoking was unexpected given previous evidence of associations between smoking and follicular lymphoma (which is largely t(14; 18)-positive). Future studies characterizing additional molecular characteristics of t(14; 18)-negative NHL may help determine whether the association with smoking may have been causal versus an artifact of chance or bias.
OBJECTIVE: We re-evaluated reported associations between tobacco use and other factors and non-Hodgkin lymphoma (NHL) t(14; 18)-subtypes based on fluorescence in situ hybridization (FISH) assays believed to be more sensitive than polymerase chain reaction (PCR), previously used for detecting t(14; 18). METHODS: Commercial FISH assays and bcl-2 immunostaining were performed on paraffin sections to determine t(14; 18) and bcl-2 case-subtypes. Polytomous logistic regression models estimated associations between NHL case-subtypes (versus 1,245 population-based controls) and tobacco use as well as other factors. RESULTS: Adjusting for age, state, and proxy status, t(14; 18)-negative NHL was associated with any tobacco use (vs. no tobacco use, OR = 1.9, 95% CI = 1.0-3.5), including current smoking (vs. no cigarette use, OR = 1.9, 95% CI = 1.1-3.2). Tobacco exposures were not clearly associated with t(14; 18)-positive NHL or bcl-2 case-subtypes. Hair-dye use and family history of a hemolymphatic cancer were associated with t(14; 18)-negative NHL, but the number of exposed cases was small. CONCLUSIONS: The association between t(14; 18)-negative NHL and cigarette smoking was unexpected given previous evidence of associations between smoking and follicular lymphoma (which is largely t(14; 18)-positive). Future studies characterizing additional molecular characteristics of t(14; 18)-negative NHL may help determine whether the association with smoking may have been causal versus an artifact of chance or bias.
Authors: Sharon L Barrans; Paul A S Evans; Sheila J M O'Connor; Roger G Owen; Gareth J Morgan; Andrew S Jack Journal: J Mol Diagn Date: 2003-08 Impact factor: 5.568
Authors: E Stagnaro; V Ramazzotti; P Crosignani; A Fontana; G Masala; L Miligi; O Nanni; M Neri; S Rodella; A S Costantini; R Tumino; C Viganò; C Vindigni; P Vineis Journal: Cancer Causes Control Date: 2001-05 Impact factor: 2.506
Authors: J C Schroeder; A F Olshan; R Baric; G A Dent; C R Weinberg; B Yount; J R Cerhan; C F Lynch; L M Schuman; P E Tolbert; N Rothman; K P Cantor; A Blair Journal: Cancer Causes Control Date: 2002-03 Impact factor: 2.506
Authors: Cindy M Chang; Jane C Schroeder; Wen-Yi Huang; Cherie H Dunphy; Ralph S Baric; Andrew F Olshan; Kathleen C Dorsey; Georgette A Dent; James R Cerhan; Charles F Lynch; Nathaniel Rothman; Kenneth P Cantor; Aaron Blair Journal: Leuk Res Date: 2009-06-07 Impact factor: 3.156
Authors: A Godon; A Moreau; P Talmant; L Baranger-Papot; F Geneviève; N Milpied; M Zandecki; H Avet-Loiseau Journal: Leukemia Date: 2003-01 Impact factor: 11.528
Authors: L M Morton; T R Holford; B Leaderer; P Boyle; S H Zahm; Y Zhang; S Flynn; G Tallini; B Zhang; P H Owens; T Zheng Journal: Br J Cancer Date: 2003-12-01 Impact factor: 7.640
Authors: Catherine Bulka; Loretta J Nastoupil; Jean L Koff; Leon Bernal-Mizrachi; Kevin C Ward; Jessica N Williams; A Rana Bayakly; Jeffrey M Switchenko; Lance A Waller; Christopher R Flowers Journal: South Med J Date: 2016-10 Impact factor: 0.954
Authors: Cindy M Chang; Sophia S Wang; Bhavana J Dave; Smrati Jain; Mohammad A Vasef; Dennis D Weisenburger; Wendy Cozen; Scott Davis; Richard K Severson; Charles F Lynch; Nathaniel Rothman; James R Cerhan; Patricia Hartge; Lindsay M Morton Journal: Int J Cancer Date: 2010-11-23 Impact factor: 7.396
Authors: Carsten Hirt; Kerstin Weitmann; Frank Schüler; Thomas Kiefer; Charles S Rabkin; Wolfgang Hoffmann; Gottfried Dölken Journal: Leuk Lymphoma Date: 2013-05-07